Corriente Advisors, LLC Uni Qure N.V. Transaction History

Corriente Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 03, 2020	SELL	$35.98 - $47.66 $6.48 Million - $8.58 Million	-180,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$45.06 - $67.74 $8.11 Million - $12.2 Million	180,000 New	180,000 $8.11 Million
Q1 2020 May 18, 2020	SELL	$40.01 - $73.97 $10.1 Million - $18.7 Million	-252,500 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $9.38 Million - $18.8 Million	252,500 New	252,500 $18.1 Million

154

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $793M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Corriente Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Corriente Advisors, LLC with notifications on news.